Commentary: Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
Main Authors: | Tauseef A. Khan, John L. Sievenpiper, John D. Fernstrom |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2021.725786/full |
Similar Items
-
Meal Replacements for Weight-Related Complications in Type 2 Diabetes: What Is the State of the Evidence?
by: Jarvis C. Noronha, et al.
Published: (2022-07-01) -
The ecologic validity of fructose feeding trials: Supraphysiological feeding of fructose in human trials requires careful consideration when drawing conclusions on cardiometabolic risk
by: Vivian L Choo, et al.
Published: (2015-05-01) -
Dietary Glutamic Acid, Obesity, and Depressive Symptoms in Patients With Schizophrenia
by: Pooja Kumar, et al.
Published: (2021-01-01) -
Simulation model to assess the validity of the clinical portfolio diet score used in the PortfolioDiet.app for dietary self-tracking: a secondary analysis of a randomized controlled trial in hyperlipidemic adults
by: Meaghan E. Kavanagh, et al.
Published: (2024-08-01) -
Differential Effects of Dietary MSG on Hippocampal Dependent Memory Are Mediated by Diet
by: Kathleen F. Holton, et al.
Published: (2019-09-01)